Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report

di Wang, Tao, Wang, Ruimin, Dong, Zhouhuan, Liang, Naichao, Chang, Ping
Pubblicato in Open Med (Wars) (2016)

Patients with advanced non-small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real-world data anal...

di Chang, Nijia, Duan, Jingjing, Wang, Lingxiong, Dong, Zhouhuan, Liu, Zhefeng
Pubblicato in Oncol Lett (2020)

Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes

di Wang, Tao, Liu, Yang, Zhou, Bin, Wang, Zhi, Liang, Naichao, Zhang, Yundong, Dong, Zhouhuan, Li, Jie
Pubblicato in Onco Targets Ther (2016)

Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients

di Dong, Zhouhuan, Kong, Linghong, Wan, Zhiyi, Zhu, Fengwei, Zhong, Mei, Lv, Yali, Zhao, Po, Shi, Huaiyin
Pubblicato in Sci Rep (2019)

GLI1 activation is a key mechanism of erlotinib resistance in human non-small cell lung cancer

di Dong, Zhouhuan, Wang, Yun, Ding, Vivianne, Yan, Xiang, Lv, Yali, Zhong, Mei, Zhu, Fengwei, Zhao, Po, He, Charlotte, Ding, Feng, Shi, Huaiyin
Pubblicato in Oncol Lett (2020)

The different expression of glycogen phosphorylases in renal clear cell renal carcinoma and chromophobe renal carcinoma

di Lu, Yang, Luo, Guangda, Zhu, Songbiao, Wang, Xu, Chen, Yuling, Dong, ZhouHuan, Wang, Shiyu, Ma, Jie, Deng, Haiteng, Wu, Di, Dong, Jun
Pubblicato in Clin Proteomics (2020)

Catalog of Lung Cancer Gene Mutations Among Chinese Patients

di Xue, Xinying, Asuquo, Idorenyin, Hong, Lei, Gao, Jie, Dong, Zhouhuan, Pang, Li, Jiang, Tianjiao, Meng, Mingming, Fan, Jingbo, Wen, Jiaxin, Deng, Hui, Zang, Xuelei, Ma, Xidong, Guo, Rui, Qin, Chong, Meng, Yao, Ma, Heji, Han, Jun, Wang, Haijiao, Xue, Zhiqiang, Zhao, Dahai, Lin, Dongliang, Pan, Lei
Pubblicato in Front Oncol (2020)